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Abstract
Diethyl pyrocarbonate (DEPC) in conditions that favour carbethoxylation of histidyl residues strongly inactivated E-type
ATPase activity of a rat lung membrane preparation, as well as ecto-ATPase activity of rat vessels and human Epstein^Barr
virus-transformed B lymphocytes. Inactivation of the enzyme (up to 70%) achieved at concentrations of DEPC below 0.5
mM could be fully reversed by 200 mM hydroxylamine at pH 7.5, thus confirming histidine-selective modification. UTP
effectively protected the enzyme activity from DEPC inactivation. This was taken to indicate that the conformation adopted
by the enzyme molecule upon substrate binding was not compatible with DEPC reaching and/or modifying the relevant
histidyl residue. Substrate activation curves were interpreted to show the enzyme molecule to be inactive, at all substrate
concentrations tested, when the target histidyl residue had been modified by DEPC. Comparison of known sequences of
CD39-like ecto-ATP(D)ases with the results on inactivation by DEPC revealed His-59 and His-251 (according to the human
CD39 sequence) as equally possible targets of the inactivating DEPC modification. Potato apyrase lacks a homologue for the
former residue, while the latter is preserved in the enzyme sequence. Therefore, this enzyme was exposed to DEPC, and since
hydrolysis of ATP and ADP by potato apyrase was insensitive to modification with DEPC, it was concluded that His-59 is
the essential residue in CD39 that is affected by DEPC modification in a way that causes inactivation of the enzyme. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
E-type ATPases are enzymes that hydrolyse phos-
phoanhydride bonds in various nucleoside tri- and/or
diphosphates; they show an obligatory requirement
for divalent cations without strict selectivity between
Ca2 and Mg2, and they are insensitive to com-
monly used inhibitors of F-type, P-type and V-type
ATPases [1]. Structurally, some of the E-type ATP-
ases originated from mutually unrelated protein fam-
ilies [2^8], but the largest, widely distributed group of
these enzymes belongs to the CD39-like family of
proteins. Lymphoid cell activation antigen CD39
and potato apyrase are prototypes for membrane-
bound and soluble forms, respectively, of members
of this family [2,9,10] which includes a broad variety
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of enzymes expressed from protozoa and plants to
mammalians. Membrane-bound forms are found
preferentially, but not exclusively, in the plasma
membrane, where the catalytic site of the protein is
located at the extracellular side. Members of the fam-
ily di¡er in substrate speci¢city and in ability to hy-
drolyze nucleoside di- and triphosphates. Some mem-
bers, like the enzymes from chicken gizzard [11] and
rat brain [12], are ATPases, exhibiting a high selec-
tivity to nucleoside triphosphates only, while e.g.
CD39s and potato apyrase are ATP diphosphohy-
drolases (ATPDases), or apyrases, hydrolysing nu-
cleoside di- and triphosphates almost equally well
[9,13,14]. Still other members of the family, like the
chicken oviduct enzyme [15] and HB6 from human
brain [16], show an intermediate selectivity. It has
not yet been unambiguously established how the dif-
ferences in substrate speci¢city relate to structural
di¡erences, but it is noteworthy that cells may co-
express these enzymes [12], indicating that they may
di¡er with respect to function.
Comparison of sequences revealed that CD39-like
proteins all contain ¢ve apyrase conserved regions
(ACRs) [2,17,18]. Analysis of these regions disclosed
certain motifs that are conserved also in functionally
important regions of proteins that belong to the well-
characterised actin/hsp70/sugar kinase superfamily
[2]. In CD39-like proteins, site-directed mutagenesis
of residues with established function in the actin/
hsp70/sugar kinase superfamily is a promising ap-
proach to elucidate critical residues and structural
elements involved in the enzymatic function [17,19].
An alternative approach in the search for function-
ally important regions and residues may be provided
by a selective chemical modi¢cation.
Diethyl pyrocarbonate (DEPC) is a widely used
tool in chemical modi¢cation of proteins because of
the high selectivity of the reagent to histidyl residues
[20]. Even though ‘silent’ modi¢cations not a¡ecting
the enzymatic function may take place, modi¢cation
with DEPC was successfully used in studies of vari-
ous groups of enzymes, e.g. ribonucleases, proteases
and P-type ATPases [20^22]. In studies on various E-
type ATPases, inactivation of the enzyme by DEPC
was ¢rst demonstrated for rabbit and chicken trans-
verse tubule ATPases, and histidyl residues were sug-
gested as the target of the inactivating modi¢cation
[23,24]. Recently, inactivation of E-type ATPases in
cardiac, renal and intestinal rat membranes, as well
as in chicken gizzard and liver membranes, has been
demonstrated [25,26], but sequence information [11]
is available for only one of these DEPC-sensitive
enzymes [26].
This paper is focused on selecting for DEPC mod-
i¢cation, by search among cell types and species,
some CD39-like proteins that contain sequences
that may provide information enabling distinction
between di¡erent possible targets of the enzyme-in-
activating modi¢cation. In this way, human CD39,
rat CD39 and potato apyrase were selected. By com-
paring the inactivation results with the correspond-
ing enzymes’ sequences, evidence was obtained indi-
cating that His-59, according to the sequence of
human CD39, is the most plausible target of modi-
¢cation by DEPC. This residue seems to have an
important functional signi¢cance in the enzymatic
catalysis.
2. Materials and methods
2.1. Materials
RPMI 1640 medium was obtained from Gibco
Laboratories, USA, foetal calf serum was from Bio-
logical Industries, Israel, [Q-32P]ATP was from Amer-
sham, isopropanol and extra-pure ethanol were from
Merck. All other reagents were supplied by Sigma.
Potato apyrase was grade V from Sigma that exhibits
hydrolysis of both ATP and ADP.
2.2. Enzyme sources
In studies on membrane-bound enzymes, three dif-
ferent well-established experimental systems were
used that had in common CD39 expression: (1) Ep-
stein^Barr virus-transformed lymphoblastoid B cells
(EBV-B cells) where human CD39 was ¢rst discov-
ered and best characterised [2,9,10], (2) rat lung
membranes, and (3) mesenteric small arteries, both
enriched in CD39, and the latter allowing repeated
treatment and assay of the same material. EBV-
transformed lymphoblastoid cells JY were grown in
a RPMI 1640 medium supplemented with 10% heat-
inactivated foetal calf serum and antibiotics, and
used in the logarithmic phase of growth. Before ex-
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periments, the cells were sedimented at 500Ug for
7 min and washed twice in a 5-fold volume of a me-
dium, HB, consisting of (mM): N-(2-hydroxyethyl)-
piperazine-NP-2-ethanesulfonic acid (HEPES) 20, glu-
cose 10, NaCl 150, CaCl2 2, pH 7.5.
Rat mesenterium was isolated from male Wistar
rats and placed in ice-cold physiological salt solution,
PSS, pH 7.5, containing, mM: HEPES 5, NaCl 120,
KCl 4.6, KH2PO4 1.2, MgSO4 1.2, EDTA 0.026,
NaHCO3 25, glucose 5.5 and CaCl2 2.5. Segments
of vessels were dissected free of fat and connective
tissue. Before incubation and assay of ecto-ATP-
ase activity in PSS, the segments were weighted
[27,28].
The post-mitochondrial membrane fraction from
rat lungs was isolated from tissue, homogenised in
30 mM histidine, pH 7.4, containing 7.7% sucrose
and 0.1 mM EDTA, by di¡erential centrifugation
(at 10 000Ug for 15 min and centrifugation of the
supernatant at 100 000Ug for 1 h). The resulting
pellet was resuspended in the same solution, but his-
tidine was replaced with HEPES, 30 mM, and the
speci¢c activity determined to be 4.6 U per mg of
protein. Protein was measured according to the Coo-
massie brilliant blue technique [29] using BSA as a
standard.
2.3. Modi¢cation by DEPC
Serial dilutions of DEPC were prepared in dry
ethanol and the actual DEPC concentration was de-
termined by reaction with 10 mM imidazole [20].
EBV-B cell samples, suspended in HB, were placed
on ice for 5 min, and DEPC in ethanol or ethanol
alone (5% ¢nal concentration) was added to the sam-
ples. After 20^30 min at 4‡C, the modi¢cation was
terminated by adding a 5-fold molar excess over
DEPC of histidine bu¡er, pH 7.5. The concentration
of cells during DEPC treatment was 2.5^5U105cells/
ml. When DEPC modi¢cation in the presence or
absence of 2.5 mM UTP was compared, more dilute
samples (2U105 cells in 2 ml of HB) were used, so
that the decrease in substrate concentration due to
enzymatic hydrolysis did not exceed 5%. After mod-
i¢cation, samples were washed twice with HB. When
studying the pH-dependence of DEPC inactivation,
cells were washed in HB bu¡er adjusted to pH 6.0,
6.5, 7.0 or 7.5, suspended in HB of the corresponding
pH and DEPC modi¢cation was performed as
above. Reversal of DEPC inactivation was studied
using EBV-B cells modi¢ed at pH 7.5. After washing
and resuspending in HB, the cells were treated with
200 mM hydroxylamine, added from a 1 M stock
solution of hydroxylamine in HB, adjusted to pH
7.5. The mixture was incubated at 4‡C for 10^30
min, diluted 5-fold by HB, and cells were sedimented
and washed, as above. Rat artery segments were
treated with DEPC in PSS at 4‡C for 30 min, and
the rat lung membrane preparation was modi¢ed
under the same conditions, but in HEPES bu¡er
(30 mM, pH 7.4), and the protein concentration dur-
ing modi¢cation was 43 Wg/ml. The control and the
modi¢ed membrane preparations were diluted 1000
times in the assay. In the experiment (Fig. 6) showing
protection by UTP from DEPC inactivation, 2.5
nmol of UTP was added to each assay with the en-
zyme source. This could be taken into account cal-
culating the concentration and the speci¢c radioac-
tivity of the combined substrate, ATP and UTP,
since it was shown [30] that both nucleotides serve
equally well as substrates for the rat lung enzyme.
Potato apyrase was dialysed against HB prior to
DEPC modi¢cation.
2.4. Determination of nucleotide hydrolytic activity
Ecto-ATPase activity of EBV-B cells and rat mes-
enteric arteries, as well as E-type ATPase activity of
the rat lung membrane fraction were determined as
the rate of enzymatic Pi release from nucleoside tri-
or diphosphate. Control and DEPC-treated EBV-B
cells were suspended in HB. Aliquots were drawn for
cell counting in a Coulter Multisizer II (Counter
Electronics, Northwell Drive, UK). Routinely, the
standard assay was performed in 96-well plates for
tissue cell culture (Greiner). Duplicate samples of
0.05^0.1 ml of cell suspension (104 cells) were added
to preheated HB containing sodium orthovanadate,
oligomycin and ATP, so that the ¢nal concentrations
in the assay were 0.1 mM, 10 WM and 1 mM, respec-
tively, in 0.3 ml total volume. Plates were covered by
a plate sealer and incubated in a water bath at 37‡C
during 15^30 min. The reaction was terminated by
placing the plate on ice and adding 30 Wl 6 N H2SO4.
Samples were centrifuged for 3 min at 400Ug, and
the amount of Pi released from ATP was determined
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in the supernatants using two colourimetric proce-
dures of di¡erent sensitivity [31,32], modi¢ed as de-
scribed previously [4]. Two values, non-enzymatic Pi
release from ATP into the assay medium during in-
cubation without cells and the Pi content in samples
incubated without ATP, were subtracted from the
total Pi release giving values for the enzymatic ATP
hydrolysis. KH2PO4 was used as a standard. Ecto-
ATPase activity of the EBV-B cells (in a logarithmic
phase of growth) was 67 þ 14 mU/106 cells. The assay
for ADP hydrolysis contained additionally 0.2 mM
diadenosine pentaphosphate. The actual concentra-
tions of all nucleoside di- and triphosphates were
determined spectrophotometrically, and the enzy-
matic hydrolysis of ADP, GTP, CTP and UTP was
measured according to the procedure described for
ATP.
For measuring the ecto-ATPase activity of rat
small mesenteric artery, each segment of rat mesen-
teric artery (average weight 2 mg per segment) was
preincubated at 37‡C for 2 min in 450 Wl of PSS.
Fifty Wl of 10 mM [32P]ATP (speci¢c activity 600
cpm per nmol) was added, and hydrolysis allowed
to proceed at 37‡C for 10 min. At the end of the
assay, the segment was removed/transferred and the
incubation medium placed on ice. Upon the addition
of 50 Wl of ice-cold 50% TCA, 32Pi was extracted and
determined according to [33]. Corresponding to each
set of conditions, [32P]ATP hydrolysis was measured
in incubations without vessel and the value sub-
tracted as blank [27,28]. Average ecto-ATPase activ-
ity was 3.9 U/g of tissue.
The E-type ATPase activity of rat lung membrane
preparation was measured in an assay volume of 0.5
ml, and the assay medium consisted of, WM: Mg2 2,
sodium orthovanadate 50, oligomycin 6, NEM 500
and levamisole 1000, in 30 mM HEPES bu¡er (pH
7.4 at 37‡C) with 20 mM of NaCl. After 10 min at
37‡C, the reaction was stopped adding 50 Wl of ice-
cold 50% TCA on ice, and released Pi was deter-
mined according to [33]. In the standard assay (Fig.
2), the concentration of Ca2 and [32P]ATP was 50
WM, whereas Ca2 and [32P]ATP varied in parallel in
the kinetic experiment shown in Fig. 6. In both cases,
the speci¢c activity of [32P]ATP was 2^4U104 cpm/
nmol and the quantity of enzyme added between 0.01
and 0.2 mU [27,28].
3. Results
The ecto-ATPase activity of rat small mesenteric
arteries was previously characterised in details
[27,28]. The enzyme belongs to the CD39 family [34].
In Fig. 1 are shown the results obtained when the
ecto-ATPDase of rat small arteries was modi¢ed by
DEPC. This enzyme source enables a quantitative
transfer, repeated treatment and repeated assay of
the same material: the ecto-ATPase activity of nine
segments was determined (¢rst assay), and in the
following 30 min, three segments (group A) were
incubated with DEPC (0.5 mM), while six segments
(group B and C) were incubated as control, at 4‡C.
At the end of the incubation, each of the nine seg-
ments was assayed again (second assay). During the
next 30 min, another three segments (group B) were
incubated with DEPC (0.5 mM), while the six seg-
ments in group A and C were incubated as control,
Fig. 1. Inactivation of ecto-ATPase activity of mesenteric artery
segments by DEPC modi¢cation. The ecto-ATPase activity of
nine segments was determined in PSS with 1 mM [Q-32P]ATP
(1st assay), and in the following 30 min, three segments (group
A, R) were incubated with DEPC (0.5 mM) in PSS, while six
segments (group B, b, and C, F) were incubated as control, at
4‡C. At the end of the incubation, each of the nine segments
was assayed again (2nd assay). During the next 30 min, another
three segments (group B) were incubated with DEPC (0.5 mM),
while the six segments in group A and C were incubated as
control, at 4‡C. Finally, all nine segments were submitted to
the 3rd assay of ecto-ATPase activity. Corresponding to each
transfer, from assay to incubation and back, the segments were
thoroughly rinsed in PSS. Remaining ecto-ATPase activity in
the 2nd and 3rd assay is expressed as percent of the activity
measured in the 1st assay of the individual segment. (The mean
of the latter value was 3.9 U/g of tissue).
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at 4‡C. Finally, all nine segments were submitted to
the third assay of ecto-ATPase activity. Correspond-
ing to each transfer, from assay to incubation and
back, the segments were thoroughly rinsed in PSS.
Remaining ecto-ATPase activity in the second and
third assay is expressed as percent of the activity
measured in the ¢rst assay of the individual segment.
(The mean of the latter value was 3.9 U/g of tissue).
The decline in ecto-ATPase activity in the controls
(group B: between ¢rst and second assay, and group
C: between ¢rst and second and between second and
third assay) is caused by substrate inactivation dur-
ing the assay period(s) [1,27]. DEPC treatment of
group A resulted in a strong decrease in the enzy-
matic activity to 13% of the initial level, while the
control vessels (groups B and C) retained 83% of the
initial ecto-ATPase activity. Thus, in comparison to
the control, activity dropped to 15.7%. After DEPC
treatment of group B, the ecto-ATPase activity was
reduced to 7% of the initial level, or to 11% if com-
pared to the control (group C) that fell to 65% of the
initial level of activity. No recovery of the enzymatic
activity (between second and third assay) could be
observed in the vessels of group A, indicating that
the modi¢cation was stable and recycling of the en-
zyme was not observed. Thus, DEPC modi¢cation
strongly inactivates ecto-ATPase activity of rat mes-
enteric small arteries, and the degree of substrate-de-
pendent inactivation, that precedes DEPC-treatment,
does not seem to in£uence the sensitivity of the en-
zyme to DEPC inactivation.
CD39/ecto-ATPDase was ¢rst discovered in EBV-
B cells, where it was characterised as the only enzyme
hydrolysing extracellular ATP [9]. In Fig. 2 are
shown the results of DEPC modi¢cation of these
cells, as well as of rat lung membranes, known to
highly express CD39 [12,34]. The ecto-ATPase activ-
ity of EBV-B cells and the E-type ATPase activity of
rat lung membranes are inactivated to the same ex-
tent by DEPC (Fig. 2), and the sensitivity of these
enzymes to DEPC is comparable with that of the
enzyme in rat mesenteric small arteries (Fig. 1). Since
CD39 is capable of hydrolysing various nucleoside
di- and triphosphates, we next tested the substrate
speci¢city of DEPC-inactivated CD39 (Fig. 3). Mod-
i¢cation by DEPC, terminated by excess of histidine,
led to inactivation of all the enzymatic activities of
CD39 in EBV-B cells : ADP hydrolysis was reduced
Fig. 2. Inactivation by modi¢cation with DEPC of the ecto-
ATPase activity in human EBV-B cells and of E-type ATPase
activity in rat lung membranes. EBV-B cells (F) and rat lung
membranes (O) were incubated with the indicated DEPC con-
centrations at 4‡C at pH 7.5 in HB or HEPES (30 mM, pH
7.4), respectively. After 30 min, the reaction was terminated by
adding a 5-fold molar excess of histidine, pH 7.5, over DEPC.
The remaining activity was measured in the standard assay of
each enzyme source and expressed in percent of the initial ac-
tivity.
Fig. 3. Inactivation by DEPC treatment of nucleotide hydroly-
sis catalysed by ecto-ATPDase of EBV-B cells. For 20 min,
EBV-B cells were incubated (see legend to Fig. 2) with the indi-
cated DEPC concentrations, then the hydrolytic activity was
measured in aliquots of the cell suspension and expressed in
percent of the initial activity in each experiment. The hydrolytic
activity was measured in HB supplemented with 0.1 mM ortho-
vanadate and 10 WM oligomycin using the indicated nucleotides
at 1 mM as substrates. The control activity in hydrolysis of
ATP, ADP, GTP, CTP and UTP was 67.8 þ 2.0, 48.9 þ 1.6,
62.7 þ 2.2, 66.5 þ 1.2, 73.7 þ 1.9 mU/106 cells, respectively
(mean þ S.E.M. of three independently grown cell cultures, du-
plicate samples).
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to the same extent as ATP hydrolysis, but the hydro-
lysis of pyrimidine nucleoside triphosphates was sup-
pressed by DEPC modi¢cation slightly more than
hydrolysis of purine nucleoside triphosphates (Fig.
3).
DEPC has a high selectivity to histidyl residues,
but it is capable of modifying also tyrosyl, lysyl,
arginyl and cysteinyl residues [20]. Two criteria are
commonly used to distinguish between the possible
target residues [20]: (1) the pH-dependence of the
modi¢cation: this is determined by pK of the side
chain group of the residue, and (2) reversibility of
the modi¢cation by treatment with hydroxylamine,
which is rapid in the case of carbethoxylated histidyl,
but is also possible if a tyrosyl residue is modi¢ed.
Fig. 4a shows the relationship between DEPC inac-
tivation of ecto-ATPase in EBV-B cells and pH dur-
ing DEPC modi¢cation. At all tested pH values, the
inactivation follows a single exponential dependence
on the concentration of the modifying reagent, and
the obtained pH pro¢le is most consistent with car-
bethoxylation of the imidazole group in histidyl res-
idue [20] as has been proposed formerly [23,24,26].
This conclusion is further supported by the rapid
reversibility of the enzyme inactivation upon treat-
ment with 200 mM hydroxylamine, consistent with
decarbethoxylation of modi¢ed histidyl residues (Fig.
4b). At low DEPC concentrations, recovery of the
enzymatic activity is almost complete in 10 min if
compared to the activity of control EBV-B cells
treated only with 200 mM hydroxylamine. Restora-
tion was 82% and 76% for the preparations modi¢ed
with 1 mM and 2 mM DEPC, respectively (Fig. 4b).
Recovery of the enzymatic activity did not increase if
the treatment with hydroxylamine was extended to
30 min (not shown). Incomplete recovery of the ac-
tivity could be the result of a concomitant modi¢ca-
tion of another, not histidyl, target residue. The in-
crease in the fraction of irreversibly inactivated
ATPase with increase in DEPC concentration may,
however, alternatively point to a formation of a di-
substituted histidyl derivative. Such a compound is
known to be insensitive to treatment with hydroxyl-
amine [20].
Inactivation of the ecto-ATPase activity in EBV-B
cells could be prevented if the substrate of the en-
zyme was present during DEPC treatment (Fig. 5).
In the presence of 2.5 mM UTP, protection of the
enzyme was observed at all DEPC concentrations
tested, but protection was most e¡ective at a higher
ratio of substrate over modi¢er concentration. Thus,
while more than half of the enzymatic activity was
lost during modi¢cation with 0.2 mM DEPC alone,
inactivation was prevented almost completely by the
presence of 2.5 mM UTP during DEPC treatment
(Fig. 5). In rat mesenteric small vessels, the presence
of substrate (UTP) prevented inactivation of the
ecto-ATPDase by DEPC (not shown), but since the
presence of substrate alone causes inactivation of the
enzyme (decreased substrate a⁄nity) in intact rat
vessels [27], the interpretation of these experiments
is di⁄cult. Protection from DEPC inactivation of
Fig. 4. pH-dependence of DEPC-induced inactivation of the
ecto-ATPase activity of EBV-B cells (a) and (b) reversal of the
inactivation by hydroxylamine. (a) Cells were washed with HB
adjusted to pH 6.0, 6.5, 7.0 or 7.5. DEPC modi¢cation was
performed at the same pH; (b) after modi¢cation at pH 7.5
with the indicated DEPC concentrations, cells were sedimented,
suspended in HB and divided into two portions. One was kept
without treatment, while hydroxylamine from a stock 1 M solu-
tion, pH 7.5, in HB was added to the other (¢nal concentration
200 mM). After incubation for 10 min at 4‡C, all suspensions
were diluted 5-fold in HB, washed twice, sedimented, resus-
pended end counted. Aliquots were drawn for measuring the
ecto-ATPase activity of the cells treated with hydroxylamine
after DEPC modi¢cation (R) or left without treatment after
the modi¢cation (F).
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E-type ATPase activity of rat lung membranes could
be demonstrated (Fig. 6), and also in this enzyme
source was the protective e¡ect dependent on the
ratio between substrate and modi¢er concentration
(not shown). Since pyrimidine nucleotides, unlike pu-
rines [20], do not react directly with DEPC, it is
binding of the substrate to the enzyme that prevents
modi¢cation of a functionally essential histidyl resi-
due due to a steric hindrance or a conformational
transition in the protein, which a¡ects either reactiv-
ity or accessibility of the target. Fig. 6 shows double
reciprocal plots for E-type ATPase of rat lung mem-
branes in control preparations and preparations
modi¢ed by DEPC in the absence or presence of
UTP. After modi¢cation, samples were 1000-fold di-
luted in the assay where ATPase activity was deter-
mined by measuring radioactive phosphate release
from [Q-32P]ATP, keeping an equimolar ratio of Ca
and ATP over a broad range of substrate concentra-
tions. DEPC modi¢cation decreased the maximal ve-
locity of ATP hydrolysis, and the presence of UTP
during DEPC treatment prevented this inactivation
of the enzyme (Fig. 6). A decrease in the maximal
velocity was obtained also when comparing hydroly-
sis of UTP by ecto-ATPase of DEPC-modi¢ed and
control EBV-B cells (not shown). The observed ki-
netic patterns are compatible with an impaired cata-
lytic step or complete inactivation of the part of the
molecules, while non-modi¢ed molecules bind and
hydrolyse substrate as before [35].
Search for a possible target of DEPC modi¢cation
should focus on histidyl residues conserved in the
CD39 family of proteins, and comparison of sequen-
ces of membrane-bound and soluble members re-
vealed only ¢ve conserved histidyl residues to be con-
sidered. The regions of the polypeptide chains, which
include these conserved histidyl residues, are pre-
sented in Table 1. The conserved histidyl residue
found closest to the C-terminal, His-474, is preserved
only in all CD39s, but not in other enzymes belong-
ing to the CD39 family of proteins. Since chicken
gizzard ecto-ATPase lacks this residue, and since
DEPC was shown to inactivate this enzyme activity
[26], His-474 could not be the target of the inactivat-
ing modi¢cation. For the same reason, His-438 could
be excluded, and His-121 was discarded as a possible
candidate, since this residue is absent in rat CD39
and chicken oviduct ATPDase, and since the former
enzyme was shown to be DEPC-sensitive in the
present work. The remaining two conserved histidyl
residues were His-251, found in all the discussed se-
quences (Table 1), and His-59, that is missing in HB6
and potato apyrase.
Thus, the sensitivity of potato apyrase to DEPC
Fig. 6. Double reciprocal plots of substrate curves of the E-
type ATPase activity of rat lung membranes. Control prepara-
tions (F), enzyme-treated with 0.2 mM DEPC (R) and enzyme-
treated with 0.2 mM DEPC in the presence of 5 mM UTP
(P). In the latter case, 2.5 nmol of UTP was added to each as-
say with the enzyme source. This was taken into account calcu-
lating the concentration and the speci¢c radioactivity of the
combined substrates ATP and UTP.
Fig. 5. Protection against DEPC inactivation by the substrate
of EBV-B cell ecto-ATPase activity. Cells were incubated at
4‡C in HB with the indicated DEPC concentrations, in the ab-
sence (dark columns) or the presence (light columns) of 2.5
mM UTP. After 20 min incubation, cells were washed, counted
and the ecto-ATPase activity determined. The enzymatic activ-
ity remaining after modi¢cation is expressed as percent of the
activity of the control sample containing all the added com-
pounds except DEPC (mean þ S.E.M. of ¢ve experiments).
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inactivation was used to distinguish between His-59
and His-251 as possible targets of DEPC inactiva-
tion. As shown in Fig. 7, there is a drastic di¡erence
between the enzymatic activities of human CD39 and
potato apyrase in their sensitivity to DEPC inactiva-
tion. In control experiments, stabilisation of CD39
oligomers in EBV-B cells by cross-linking at pH 8.8
with 10 mM dimethyl pimelimidate [4], either in the
absence or the presence of ATP, did not result in the
occurrence of a DEPC-insensitive fraction of ecto-
ATPDase (not shown). Since the ATPase and the
ADPase activity of potato apyrase were insensitive
to DEPC modi¢cation, this points to His-59 as the
most likely target of DEPC inactivation.
4. Discussion
Identi¢cation of residues that are essential for the
catalytic function of CD39-like proteins contributes
importantly to the elucidation of the underlying re-
action mechanism. Recent cloning and sequencing of
a number of these proteins has led to the discovery in
their structure of certain motifs conserved in mem-
bers of the actin/hsp70/sugar kinase superfamily
[2,17]. Functional knowledge about residues in these
motifs was used to select targets for site-directed mu-
tagenesis [19]. In the present work, inactivation of
the enzymes caused by chemical modi¢cation by
DEPC was analysed in the context of known primary
structure and used as an independent alternative ap-
proach to search for regions and residues that are
functionally important among CD39-like proteins,
while not obligatorily conserved among other mem-
bers of the superfamily. DEPC modi¢cations of hu-
man CD39, rat CD39 and potato apyrase were eval-
uated in the perspective of previous studies [23,24,26]
Table 1
Conserved His-containing regions selected from multiple alignment of the complete sequences of membrane-bound E-type ATPases
and potato apyrase
1 2 3 4 5
Human CD39 DAGSSHTS 61 SQHQETPVYLGAT 131 VYTHSFLC 255 HIHFIGK 442 TPLSHSTY 477
Rat CD39 DAGSSHTN 61 SKQHQTPVYLGAT 131 VYTHSFLC 254 QIHFMGK 443 PPLPHSTY 478
Mouse CD39 DAGSSHTN 61 SKHHQTPVYLGAT 131 VYTHSFLC 254 QIHFMGK 442 PPLPHSTY 477
Bovine CD39 DAGSSHTS 61 IQHMETPVYLGAT 131 VYTHSFLC 255 NIHFMNK 445 PPLPHSTY 480
Human CD39L1 DAGSSHTS 52 ERHAGTPLYLGAT 122 VYTHSFLC 242 GVIFQKK 405 KGTDFSSW 441
Rat brain ecto-ATPase DAGSSHTS 52 DRHASTPLYLGAT 122 VYTHSFLC 242 EVVFQKK 428 KGTHFSSW 464
Ch.giz. ecto-ATPase DAGSSHTA 50 EKHADTPLYLGAT 120 VYTHSFLC 239 SIAFQKK 429 RSMLYNYW 465
Ch.ov. ecto-ATPDase DAGSTHTA 53 EQQWQTPTYLGAT 123 LYTHSYLC 244 NIHFSQK 430 KGHEPSLW 468
Human HB6 DAGSSRTT 69 HLHGSTPIHLGAT 139 LYTHSFQC 261 QIHFEKE 451 LPIEPPVF 487
Potato apyrase DAGSTGSR 48 ELQSETPLELGAT 127 LYVHSYLN 246 TVIHDVQ 423 Sö ö ö ö 454
Alignment was performed using the ClustalW program. The sequences and GenBank accession numbers are, respectively, human
CD39, S73813; rat CD39, U81295; murine CD39, AF037366; bovine CD39, AF005940; human CD39L1, U91510; rat brain ecto-
ATPase, Y11835; chicken gizzard ecto-ATPase; U74467, chicken oviduct ecto-ATPDase, AF041355; human HB6, AF034840; and po-
tato apyrase, U58597. The numbers on the right side of each of ¢ve columns indicate numbers of the C-terminal residue of the frag-
ment in each of the individual sequences.
Fig. 7. E¡ects of DEPC modi¢cation of EBV-B cell ecto-
ATPase activity and of potato apyrase E-type ATP(D)ase activ-
ity. Potato apyrase, dialysed against HB, and EBV-B cells were
treated with DEPC in the indicated concentrations at 4‡C dur-
ing 30 min. ATP hydrolysis by EBV-B cells (F) and ATP (a)
and ADP (S) hydrolysis by potato apyrase were measured us-
ing aliquots of the samples and expressed as percent of the con-
trol activity of the individual enzyme.
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leading to the conclusion that the target of inactivat-
ing DEPC modi¢cation is His-59 in human CD39
and homologous residues in other CD39-like E-type
ATPases.
First, inactivation by DEPC of the enzyme in rat
mesenteric small arteries, rat lung membranes and in
human EBV-B cells was demonstrated (Figs. 1 and
2). It was further shown that all the enzymatic activ-
ities expressed by CD39 were inactivated by DEPC
modi¢cation (Fig. 3). Characteristics of DEPC inac-
tivation, pH pro¢le and reversibility by hydroxyl-
amine treatment (Fig. 4a,b), indicated that the
inactivating DEPC modi¢cation resulted in carbe-
thoxylation of histidyl residue(s), as has been pro-
posed previously for some other E-type ATPases
[23,24,26]. Next, it was shown that the presence of
the substrate, UTP, protected the enzyme from
DEPC inactivation (Figs. 5 and 6). ATP may react
directly with DEPC [20], and the protective e¡ect of
this substrate [23,26] could be caused by a decrease
in the actual DEPC concentration in the presence of
ATP. But the choice of a pyrimidine substrate elim-
inated this possibility, and the protective e¡ect of
UTP against DEPC inactivation (Figs. 5 and 6) in-
dicated that a region of the enzyme containing a
critical histidyl residue was protected from DEPC
by substrate binding, possibly because the binding
of substrate was followed by a local function-associ-
ated conformational transition that prevented DEPC
modi¢cation of the target residue. On the other
hand, when the target histidyl residue was modi¢ed
by DEPC, the enzyme molecule became inactive. The
introduction of an additional bulky side group prob-
ably represented a steric disadvantage that prevented
either substrate binding or a conformational transi-
tion involved in catalysis, or both. It is consistent
with the decrease in maximal velocity seen in Fig. 6
that a fraction of the enzyme molecules had become
inactive, the rest catalysing the hydrolysis of the sub-
strate as usual. Increasing the substrate concentra-
tion did not change the proportion between the
two fractions (Fig. 6).
Search for the residue critical for DEPC inactiva-
tion (by comparing sequences of CD39-like proteins
and the corresponding DEPC sensitivity) led us to
conclude that the most probable target of DEPC
inactivation is the conserved His-59, according to
the sequence of human CD39. It is noteworthy that
this essential target residue is localised within ACR1,
i.e. one of the two ACR sequences that are conserved
in the actin/hsp70/sugar kinase superfamily [2]. The
functional signi¢cance of ACR1 and two residues
within this region, homologous to Asp-54 and Gly-
56 in CD39, has been demonstrated by deletions and
site-directed mutagenesis in human CD39 and in
HB6, respectively [17,19]. Furthermore, these two
amino acid residues that are both present in the
L-phosphate binding motif of all members of the
actin/hsp70/sugar kinase superfamily were shown to
participate in the enzymatic catalysis in various
members of the superfamily [19,36]. The inactivation
of CD39 by modi¢cation of His-59, localised in close
proximity to these two critical residues, demonstrates
further the functional signi¢cance of ACR1.
In one of the membrane-bound CD39-like ecto-
ATPases, HB6, His at this position is substituted
by Arg [16]. This may indicate that either the residue,
even though being part of the sequence in the cata-
lytic region, is not functionally signi¢cant, and
DEPC modi¢cation inactivates the enzyme solely be-
cause of steric factors, or that the function carried by
the residue at this position tolerates some substitu-
tions. Noteworthy, only HB6 sequence contains a
histidyl residue (marked in bold in Table 1) in a
very conserved part of ACR2. Since the ACRs are
assumed to be in a close proximity in the tertiary
structure [2], this histidyl could be a structural^func-
tional substitution for histidyl residue lacking in
ACR1 of HB6. Chemical modi¢cation data do not
prove directly functional signi¢cance and the role of
the particular target of the modi¢cation, but a pos-
sible function can be suggested based on conserva-
tion of the residue in a number of related sequences,
as well as by analogy with similar proteins. There are
two functionally important histidyl residues in the
structure of actin [36]. One of them, His-73, is lo-
cated close to ACR1 and, according to atomic struc-
ture data, it occupies a position where it participates
in the enzymatic catalysis by coordinating the water
molecule that attacks the Q-phosphate of ATP during
the enzymatic catalysis [36]. In hsp70, the same posi-
tion is occupied and the same function undertaken
by Lys-71 [36], indicating no strict requirement for
His in the speci¢c function. Potato apyrase is DEPC-
insensitive (Fig. 7). This enzyme contains Gly (Table
1) at the position homologous to His-59 in the CD39
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sequence. If by analogy with actin [36], His-59 has a
functional signi¢cance in E-type ATPases, (1) this
function can tolerate some amino acid substitutions,
less dramatic than introducing a hydrophobic carbe-
thoxy group into His; (2) structural limitations or
requirements put on the enzyme by this function
(which could be, for example, coordination of the
water molecule attacking Q-phosphate) may di¡er
for highly organised membrane-bound oligomer
and soluble monomeric enzyme.
In conclusion, His-59 in the sequence of CD39 and
homologous sequences in CD39-like proteins is the
most probable target for inactivation by DEPC. Fur-
ther studies are required to elucidate the molecular
mechanism behind the inactivation and roles for this
histidyl residue in the enzymatic function of E-type
ATPases.
5. Note added in proof
While this paper was under review, A. Grinthal
and G. Guidotti published results obtained by site
directed mutagenesis [Biochemistry 39 (2000) 9^16].
The results indicate that His-59 has a functional role
in ATP hydrolysis by CD39.
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